A Phase 1 study of ONO-7057 in patients with relapsed and/or refractory multiple myeloma

Trial Profile

A Phase 1 study of ONO-7057 in patients with relapsed and/or refractory multiple myeloma

Completed
Phase of Trial: Phase I

Latest Information Update: 15 May 2018

At a glance

  • Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 12 Feb 2018 Status changed from active, no longer recruiting to completed.
    • 06 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top